"While there are many drugs used to treat type 2 diabetes (sulfonylureas, DPP-4 inhibitors, SGLT-2 inhibitors, TZDs, GLP-1 agonists, etc.), these results may make Jardiance or other SGLT-2 inhibitors the standard second-line therapy (after metformin) used to treat type 2 diabetes (or potentially first-line therapy if the magnitude is really meaningful we wont know anything about that for a month, when the specifics on the results are disclosed)
Cardiovascular disease, history of stroke, or elevated inflammatory markers further strengthen the case
Specific genetic patterns influence medication sensitivity and side-effect intensity, helping personalize your injection frequency and dosing timeline
I didnt hit my goal, but I felt a lot better and more confident, Emily shared
10.1016/j.psj.2021.101622 86
Add KPV at 200 to 500 mcg per day for additional anti-inflammatory support, particularly if the injury involves significant inflammation